ATE303597T1 - Hcv mosaik antigen zusammensetzung - Google Patents

Hcv mosaik antigen zusammensetzung

Info

Publication number
ATE303597T1
ATE303597T1 AT01951273T AT01951273T ATE303597T1 AT E303597 T1 ATE303597 T1 AT E303597T1 AT 01951273 T AT01951273 T AT 01951273T AT 01951273 T AT01951273 T AT 01951273T AT E303597 T1 ATE303597 T1 AT E303597T1
Authority
AT
Austria
Prior art keywords
hcv
antigen composition
mosaic antigen
diagnostic
antibodies
Prior art date
Application number
AT01951273T
Other languages
English (en)
Inventor
Hermes K W Chan
Richard Theolis Jr
Original Assignee
Medmira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmira Inc filed Critical Medmira Inc
Application granted granted Critical
Publication of ATE303597T1 publication Critical patent/ATE303597T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01951273T 2000-07-07 2001-07-06 Hcv mosaik antigen zusammensetzung ATE303597T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2311022 2000-07-07
PCT/CA2001/000988 WO2002004484A2 (en) 2000-07-07 2001-07-06 Hcv mosaic antigen composition

Publications (1)

Publication Number Publication Date
ATE303597T1 true ATE303597T1 (de) 2005-09-15

Family

ID=4166420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01951273T ATE303597T1 (de) 2000-07-07 2001-07-06 Hcv mosaik antigen zusammensetzung

Country Status (6)

Country Link
EP (1) EP1328811B1 (de)
AT (1) ATE303597T1 (de)
AU (1) AU2001272257A1 (de)
DE (1) DE60113139T2 (de)
ES (1) ES2248357T3 (de)
WO (1) WO2002004484A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1357127A1 (de) 2002-04-10 2003-10-29 Immusystems GmbH CD4+ T-Lymphozyten spezifische Hepatitis C Virus-Epitope
US20040106526A1 (en) * 2002-12-03 2004-06-03 Baxter David Roderick Method for marking liquid hydrocarbons
EP2267004A3 (de) * 2003-09-22 2011-04-27 Green Peptide Co., Ltd. Peptide aus Hepatitis C Virus
US8475735B2 (en) 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
ZA200804078B (en) * 2005-10-13 2009-09-30 Virexx Medical Corp Chimeric hepatitis C virus antigens for eliciting an immune response
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
CA2629290C (en) * 2005-11-12 2014-05-06 Carolyn Jennifer Ruddell Agglutination assay
CA2580589C (en) 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
JP4975601B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
US20080227111A1 (en) 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
EP2209549A4 (de) 2007-10-12 2014-03-05 Fio Corp Strömungsfokussierungsverfahren und system zur bildung von konzentrierten volumina von mikrokügelchen und weiterhin gebildete mikrokügelchen
CA2729023C (en) 2008-06-25 2013-02-26 Fio Corporation Bio-threat alert system
CN105759021A (zh) 2008-08-29 2016-07-13 Fio公司 用于检测生物和环境检测样品的一次性手持式诊断检测设备和相关系统与方法
CN102348986B (zh) 2009-01-13 2015-05-06 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备和方法
EP3715374A1 (de) 2019-03-23 2020-09-30 Ablevia biotech GmbH Verbindung zur sequestrierung von unerwünschten antikörpern in einem patienten
US11986536B2 (en) 2019-03-23 2024-05-21 Ablevia Biotech Gmbh Compound for the sequestration of undesirable antibodies in a patient

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0484787B1 (de) * 1990-11-03 2001-10-10 Dade Behring Marburg GmbH HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
DK0754704T3 (da) * 1990-12-14 2000-04-03 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)

Also Published As

Publication number Publication date
EP1328811A2 (de) 2003-07-23
DE60113139D1 (de) 2005-10-06
ES2248357T3 (es) 2006-03-16
EP1328811B1 (de) 2005-08-31
AU2001272257A1 (en) 2002-01-21
DE60113139T2 (de) 2006-06-22
WO2002004484A2 (en) 2002-01-17
WO2002004484A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
DE60113139D1 (de) Hcv mosaik antigen zusammensetzung
US7402315B2 (en) Hepatitis-C virus type 4, 5 and 6
CN1360678B (zh) 借助ns1糖蛋白对黄病毒进行早期检测的方法及其应用
RU2001101869A (ru) Частицы белков оболочки HCV: применение для вакцинации
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
EP0698216B2 (de) Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
JPH06506669A (ja) Ｃ型肝炎ウィルス（ｈｃｖ）に対する抗体の検出のためのペプチド及びその混合物
CA2045323C (en) Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
KR20010042807A (ko) 환원제를 사용하는 개선된 면역진단 분석법
WO2003095968A2 (fr) Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectueux
ES2143996T5 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
EP1878797A3 (de) Antigene Peptide zur Gruppierung des Hepatitis-C-Virus, Kit damit und Verfahren zur Gruppierung unter Verwendung dieses Kits
ATE115964T1 (de) Non-a non-b sequenzen.
US5885771A (en) Antigenic peptide compound and immunoassay
IE922548A1 (en) Non-a, non-b peptide
DE60131962D1 (de) Verfahren und zusammensetzungen zum nachweis von taenia solium larven mittels eines klonierten antigens
JPH11100397A (ja) Ｃ型肝炎の感染の診断および検出に効果的なペプチド
KR960034420A (ko) 적어도 2개의 c형간염바이러스관련펩티드로 이루어진 다량체항원펩티드
CA2151126A1 (en) Peptides from the c33 region of hcv, antibodies thereto and methods for the detection of hcv
EP0829488A1 (de) Antigene peptidsubstanz und immotestverfahren
RU2000132968A (ru) Способы ускоренной диагностики гепатита с, основанные на обнаружении гемагглютининов вируса гепатита с (вгс) и антител к ним в рга и ргта в крови людей
CA2151128A1 (en) Hepatitis c virus (hcv) non-structural-3 peptides, antibodies thereto and methods for the detection of hcv
KR19990044211A (ko) 항원 펩타이드 화합물 및 면역학적 측정 방법
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same
WO2001005824A3 (en) Synthetic peptides immunoreactive with hepatitis a virus antibodies

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties